幼年型肌炎患者的肌炎相关自身抗体与难治性疾病及死亡率相关
在551例幼年型肌炎患者中,36%存在肌炎相关自身抗体(MAA),13%存在一种以上MAA。MAA阳性与重叠性肌炎、雷诺现象、间质性肺病(ILD)、慢性病程及死亡率相关,MAA数量与死亡率相关。
要点
- 551例幼年型肌炎患者中36%MAA阳性,13%存在一种以上MAA。
- MAA阳性者重叠性肌炎频率更高(18% vs 5.9%,P < 0.001)。
- MAA阳性与ILD(OR 3.43)、慢性病程(OR 1.72)及死亡率(OR 3.76)相关。
核心结论
- MAA在幼年型肌炎大型队列中常见,MAA阳性与ILD、难治性疾病及死亡率相关。
- 作者认为需要前瞻性研究来确定早期检测MAA是否能改善幼年型肌炎患者的结局。
研究设计与样本
- 横断面自然病史研究,纳入接受肌炎自身抗体检测的幼年型肌炎患者,比较有和无MAA者的 demographics、临床特征、用药及结局。
- 采用多变量逻辑回归分析MAA数量是否与严重疾病特征相关,共纳入551例患者。
主要发现
- 551例患者中36%有MAA,13%有超过一种MAA。
- MAA阳性者重叠性肌炎频率为18% vs 5.9%(P < 0.001)。
- MAA阳性与雷诺现象(OR 2.44,95%CI 1.41-4.28)、ILD(OR 3.43,95%CI 1.75-6.96)、慢性病程(OR 1.72,95%CI 1.10-2.72)及死亡率(OR 3.76,95%CI 1.72-8.43)相关。
- MAA数量与死亡率相关(OR 1.83,95%CI 1.16-2.86)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Myositis-associated autoantibodies (MAAs) have been associated with overlap myositis, certain disease manifestations such as interstitial lung disease (ILD), and worse prognosis in the idiopathic inflammatory myopathies. MAAs overall remain largely uncharacterized in patients with juvenile-onset myositis. Moreover, it is unknown whether the number of MAAs is associated with disease severity. METHODS: Patients with juvenile myositis in cross-sectional natural history studies who underwent testing for myositis autoantibodies were included. Demographics, myositis autoantibodies, clinical characteristics, medications received, and outcomes of those with and without MAAs were compared. Multivariable logistic regression was performed to determine whether the number of MAAs detected was associated with severe disease features. RESULTS: Among 551 patients, 36% had an MAA and 13% had more than one MAA. Among those who were MAA positive, there was a higher frequency of overlap myositis (18% vs 5.9%, P < 0.001). MAA positivity was associated with certain clinical features, including Raynaud phenomenon (odds ratio [OR] 2.44, 95% confidence interval [CI] 1.41-4.28) and ILD (OR 3.43, 95% CI 1.75-6.96), as well as a chronic disease course (OR 1.72, 95% CI 1.10-2.72) and mortality (OR 3.76, 95% CI 1.72-8.43). The number of MAAs was also associated with mortality (OR 1.83, 95% CI 1.16-2.86). CONCLUSION: MAAs were prevalent in a large cohort of patients with juvenile myositis. ILD, refractory disease, and mortality were associated with MAA positivity. Prospective studies are needed to determine whether early detection of MAAs may lead to improved outcomes for patients with juvenile myositis.
引用
- Sherman MA, Noroozi Farhadi P, Pak K, et al. Myositis-Associated Autoantibodies in Patients With Juvenile Myositis Are Associated With Refractory Disease and Mortality. Arthritis Rheumatol. 2024. PMID: 38272842. doi:10.1002/art.42813
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。